Ignite Creation Date:
2024-05-06 @ 5:16 PM
Last Modification Date:
2024-10-26 @ 2:25 PM
Study NCT ID:
NCT05252416
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2022-01-25
Brief Title:
VELA Study of BLU-222 in Advanced Solid Tumors
Sponsor:
Blueprint Medicines Corporation
Organization:
Blueprint Medicines Corporation
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinosarcoma |
| Advanced Solid Tumors |
| HR Breast Cancer |
| CCNE1 Amplification |
| HER2-negative Breast Cancer |
| Ovarian Cancer |
| Endometrial Cancer |
| Gastric Cancer |
| Esophageal Adenocarcinoma |